BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
See today's BioWorld
Home
» Other news to note for Oct. 8, 2020
To read the full article
sign up for free
or
sign in
.
Other news to note for Oct. 8, 2020
Oct. 8, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abveris, Aegle, Almirall, Ampio, Astrazeneca, Bayer, Betterlife, Biontech, Bristol Myers Squibb, Celgene, Cellgenix, Chromadex, Corneagen, Cytovia, Evotec, Gilead, Goldfinch, ILC, Immunitas, IMV, Intec, INSERM, Invetech, Johnson & Johnson, Kineta, Knopp, Lilly, Makana, Marinomed, Merck, Moderna, Nordic, Oblique, Oligomerix, Orbis, Pfizer, Recombinetics, Redhill, Rentschler, Roche, Santen, Seagen, Sorrento, Sumitomo, Sunovion, Translate Bio, Treefrog, Urovant, Vincera, Virtrial, Willow.
BioWorld
Briefs
Other news to note
Coronavirus